William P. Quinn - Net Worth and Insider Trading
William P. Quinn Net Worth
The estimated net worth of William P. Quinn is at least $42,643 dollars as of 2024-12-01. William P. Quinn is the CFO of Bolt Biotherapeutics Inc and owns about 36,272 shares of Bolt Biotherapeutics Inc (BOLT) stock worth over $23,236. William P. Quinn is also the See Remarks of Sunesis Pharmaceuticals Inc and owns about 3,648 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $19,407. Details can be seen in William P. Quinn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William P. Quinn has not made any transactions after 2023-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William P. Quinn
William P. Quinn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William P. Quinn owns 3 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , Viracta Therapeutics Inc (VIRX) , and Bolt Biotherapeutics Inc (BOLT) .
Click here to see the complete history of William P. Quinn’s form 4 insider trades.
Insider Ownership Summary of William P. Quinn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNSS | Sunesis Pharmaceuticals Inc | 2020-03-31 | See Remarks |
| VIRX | Viracta Therapeutics Inc | 2019-02-28 | See Remarks |
| BOLT | Bolt Biotherapeutics Inc | 2023-12-12 | Chief Financial Officer |
William P. Quinn Latest Holdings Summary
William P. Quinn currently owns a total of 2 stocks. Among these stocks, William P. Quinn owns 36,272 shares of Bolt Biotherapeutics Inc (BOLT) as of December 12, 2023, with a value of $23,236 and a weighting of 54.49%. William P. Quinn also owns 3,648 shares of Sunesis Pharmaceuticals Inc (SNSS) as of November 29, 2019, with a value of $19,407 and a weighting of 45.51%.
Latest Holdings of William P. Quinn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BOLT | Bolt Biotherapeutics Inc | 2023-12-12 | 36,272 | 0.64 | 23,236 |
| SNSS | Sunesis Pharmaceuticals Inc | 2019-11-29 | 3,648 | 5.32 | 19,407 |
Holding Weightings of William P. Quinn
William P. Quinn Form 4 Trading Tracker
According to the SEC Form 4 filings, William P. Quinn has made a total of 3 transactions in Bolt Biotherapeutics Inc (BOLT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Bolt Biotherapeutics Inc is the acquisition of 11,829 shares on December 12, 2023, which cost William P. Quinn around $11,238.
According to the SEC Form 4 filings, William P. Quinn has made a total of 0 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 343 shares on November 29, 2019, which cost William P. Quinn around $6,120.
Insider Trading History of William P. Quinn
- 1
William P. Quinn Trading Performance
GuruFocus tracks the stock performance after each of William P. Quinn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William P. Quinn is 29.39%. GuruFocus also compares William P. Quinn's trading performance to market benchmark return within the same time period. The performance of stocks bought by William P. Quinn within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William P. Quinn's insider trading performs compared to the benchmark.
Performance of William P. Quinn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.84 | | | | | |
| Relative Return to S&P 500(%) | 5.2 | | | | | |
William P. Quinn Ownership Network
William P. Quinn Owned Company Details
What does Sunesis Pharmaceuticals Inc do?
Who are the key executives at Sunesis Pharmaceuticals Inc?
William P. Quinn is the See Remarks of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks Judith A. Fox .
Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sunesis Pharmaceuticals Inc Insider Transactions
William P. Quinn Mailing Address
Above is the net worth, insider trading, and ownership report for William P. Quinn. You might contact William P. Quinn via mailing address: Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Suite 400, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
